Epidemiology of severe sepsis in critically ill surgical patients in ten university hospitals in China*-Reference-Cited by-同舟云学术

Epidemiology of severe sepsis in critically ill surgical patients in ten university hospitals in China*

Published:2007-11 Issue:11 Volume:35 Page:2538-2546
ISSN:0090-3493
Container-title:Critical Care Medicine
language:en
Short-container-title:Critical Care Medicine

Author:

Cheng Baoli,Xie Guohao,Yao ShangLong,Wu Xinmin,Guo Qulian,Gu Miaoning,Fang Qiang,Xu Qiuping,Wang Dongxin,Jin Yuhong,Yuan ShiYing,Wang Junlu,Du Zhaohui,Sun Yunbo,Fang XiangMing

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Critical Care and Intensive Care Medicine

Reference31 articles.

1. Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis

2. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference

3. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care

4. Sepsis in European intensive care units: Results of the SOAP study*

5. Incidence, Risk Factors, and Outcome of Severe Sepsis and Septic Shock in Adults

Cited by 207 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sappanone A enhances hepatocyte proliferation in lipopolysaccharide-induced acute liver injury in mice by promoting injured hepatocyte apoptosis and regulating macrophage polarization;International Immunopharmacology;2024-12

2. Advancing cell-based therapy in sepsis: An anesthesia outlook;Chinese Medical Journal;2024-05-06

3. BMAL1 alleviates myocardial damage in sepsis by activating SIRT1 signaling and promoting mitochondrial autophagy;International Immunopharmacology;2024-05

4. Inhibiting apoptosis and GSDME-mediated pyroptosis attenuates hepatic injury in septic mice;Archives of Biochemistry and Biophysics;2024-04

5. MSCs-derived extracellular vesicles alleviate sepsis-associated liver dysfunction by inhibiting macrophage glycolysis-mediated inflammatory response;International Immunopharmacology;2024-02